Suma Prakash had never smoked a day in her life. A 54-year-old schoolteacher from Kochi, she had breathed the city’s ...

What if a simple blood test could tell you that lung cancer might develop years before it actually appears? It sounds like ...

Researchers identified a 14-protein blood signature that may predict lung cancer years early, potentially enabling earlier detection and prevention. , Health, Times Now ...

Scientists have identified a blood-based protein signature that can predict lung cancer risk more than five years before diagnosis. Powered by AI and validated across global datasets, the breakthrough ...

The Nature Index 2026 Research Leaders reveal the leading institutions and countries/territories in the natural sciences, health sciences, applied sciences and social sciences, according to their ...

VIENNA — The interleukin 1 receptor antagonist (IL-1RA) canakinumab provided control of systemic juvenile idiopathic arthritis (sJIA) without the use of glucocorticoids for up to a year in most study ...

The following is a summary of “Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results From the CANOPY-1 Trial,” ...

Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy Overall, 643 patients were ...

Syringe and Vial on White Background Adjuvant canakinumab does not improve disease-free survival in patients with resected non-small cell lung cancer, data suggest. Adjuvant canakinumab does not ...

Ofranergene Obadenovec (Ofra-Vec, VB-111) With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer: Randomized Controlled Phase III Trial (OVAL Study/GOG 3018) In total, 1,382 patients were ...